$5.33
At close: Nov 12, 4:00 PM EDT
$11.74
6.41120.26%
After Hours: Nov 12, 4:00 PM EDT
Comments
Loading...
Camp4 Therapeutics (CAMP) Forecast
NewsEarningsCamp4 Therapeutics (CAMP) OptionsGuidanceDividendsAnalyst RatingsInsider TradesShort InterestCamp4 Therapeutics (NASDAQ:CAMP) Stock Quotes, Forecast and News Summary
Camp4 Therapeutics Stock (NASDAQ: CAMP) stock price, news, charts, stock research, profile.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Camp4 Therapeutics (CAMP) stock?
You can purchase shares of Camp4 Therapeutics (NASDAQ:CAMP) through any online brokerage.
Who are Camp4 Therapeutics (CAMP) competitors?
Other companies in Camp4 Therapeutics’s space includes: Outlook Therapeutics (NASDAQ:OTLK), Cabaletta Bio (NASDAQ:CABA), Invizyne Technologies (NASDAQ:IZTC), Anixa Biosciences (NASDAQ:ANIX) and Monopar Therapeutics (NASDAQ:MNPR).
What is the forecast, or price target, for Camp4 Therapeutics (CAMP) stock?
Camp4 Therapeutics has a consensus price target of $9.97.
What is the current price for Camp4 Therapeutics (CAMP)?
The stock price for Camp4 Therapeutics (NASDAQ: CAMP) is $11.74 last updated November 12, 2024 at 4:00 PM EST.
Does Camp4 Therapeutics (CAMP) pay a dividend?
There are no upcoming dividends for Camp4 Therapeutics.
When is Camp4 Therapeutics (NASDAQ:CAMP) reporting earnings?
Camp4 Therapeutics’s Q4 earnings are confirmed for Friday, February 14, 2025.
Is Camp4 Therapeutics (CAMP) going to split?
There is no upcoming split for Camp4 Therapeutics.
What sector and industry does Camp4 Therapeutics (CAMP) operate in?
Camp4 Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.